Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein–dependent and –independent pathways by cyclin‐dependent kinase 4/6
Authors:
Open Access
- 27 June 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (7) , 2074-2083
Abstract
Objective: It is known that the cyclin‐dependent kinase inhibitor (CDKI) gene p21Cip1 suppresses rheumatoid inflammation by down‐modulating type I interleukin‐1 receptor (IL‐1RI) expression and inhibiting JNK activity. The purpose of this study was to determine whether CDK activity directly modulates the production of inflammatory molecules in patients with rheumatoid arthritis (RA).Methods: Genes for the CDKIs p16INK4a and p18INK4c, a constitutively active form of retinoblastoma (RB) gene product, cyclin D1, and CDK‐4, were transferred into RA synovial fibroblasts (RASFs). RASFs were also treated with a synthetic CDK‐4/6 inhibitor (CDK4I). Levels of matrix metalloproteinase 3 (MMP‐3), monocyte chemoattractant protein 1 (MCP‐1), and IL‐1RI expression were determined by Northern blotting, real‐time polymerase chain reaction analysis, and enzyme‐linked immunosorbent assay. CDKIs were immunoprecipitated to reveal their association with JNK.Results: Transfer of the p16INK4a and p18INK4c genes and CDK4I suppressed the production of MMP‐3 and MCP‐1. Unlike p21Cip1, neither CDKI gene inhibited IL‐1RI or JNK. The expression of MMP‐3 was up‐regulated when CDK‐4 activity was augmented. This regulation functioned at the messenger RNA (mRNA) level in MMP‐3, but not in MCP‐1. Transfer of active RB suppressed the production of MMP‐3 and MCP‐1 without changing their mRNA levels.Conclusion: CDK‐4/6 modulated the production of MMP‐3 and MCP‐1. MMP‐3 production was regulated primarily at the mRNA level in an RB‐independent manner, whereas MCP‐1 production was controlled posttranscriptionally by RB. These results show that cell cycle proteins are associated with control of mediators of inflammation through multiple pathways.Keywords
This publication has 37 references indexed in Scilit:
- Matrix metalloproteinase expression and activity in human airway smooth muscle cellsBritish Journal of Pharmacology, 2004
- Synthesis, Structure−Activity Relationship, and Biological Studies of Indolocarbazoles as Potent Cyclin D1-CDK4 InhibitorsJournal of Medicinal Chemistry, 2003
- Physiology of cytokine pathways in rheumatoid arthritisArthritis & Rheumatism, 2001
- Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase‐inhibitorBritish Journal of Pharmacology, 2000
- A Simple Method for Constructing E1- and E1/E4-Deleted Recombinant Adenoviral VectorsHuman Gene Therapy, 1999
- Direct Comparison of GAPDH, β-Actin, Cyclophilin, and 28S rRNA as Internal Standards for Quantifying RNA Levels under HypoxiaBiochemical and Biophysical Research Communications, 1999
- Suppression of proliferative cholangitis in a rat model with direct adenovirus-mediated retinoblastoma gene transfer to the biliary tractHepatology, 1998
- ETS Sites in the Promoters of the Matrix Metalloproteinases Collagenase (MMP-1) Stromelysin (MMP-3) are Auxiliary Elements that Regulate Basal and Phorbol-Induced TranscriptionConnective Tissue Research, 1997
- Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.Journal of Clinical Investigation, 1992
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988